EMERGENCY REGULATION: An emergency regulation effective on June 18, 2014 places limitations and requirements on prescribing extended-release hydrocodone that lacks abuse-deterrent formulation. The purpose of the rule is to protect the public by addressing the potential for prescription drug overdose, abuse and diversion. For complete information, see Section 11.0 of the Controlled Substance Regulations.
Objective and Function
The primary objective of the Controlled Substance Advisory Committee is to promote, preserve and protect the public health, safety and welfare by regulating and monitoring use and abuse of controlled substances. To meet this objective, the Committee
The Committee issues registrations to practitioners and facilities that prescribe, dispense, manufacture and distribute controlled substances. Practitioners include physicians, physician assistants, advanced practice nurses, podiatrists, dentists and veterinarians. Facilities include pharmacies, distributors, manufacturers, hospitals, clinics, researchers, laboratories and provider pharmacies.
To assist the Committee, the Drug Control Administrator for the Division of Professional Regulation is responsible for the Committee's regular administrative functions.
The Committee meets quarterly. All meetings are open to the general public. They are usually held in the Buena Vista Conference Center, 661 S. Dupont Hwy., Buck Library, 1st Floor, New Castle, DE 19720, but the location is subject to change. Check the meeting calendar to confirm dates and location.
To ensure that business (such as a license application) is on the agenda for the Committee's consideration at its next meeting, submit all documentation to the Committee office no later than 4:30 PM ten full working days before the meeting date.